5 results match your criteria: "CNRS and Montpellier University[Affiliation]"
J Immunol
April 2024
Institute of Human Genetics, UMR9002, CNRS and Montpellier University, Montpellier, France.
Front Immunol
January 2024
Immunology Department, Nîmes University Hospital, Nîmes, France.
Background: As about 10% of patients with COVID-19 present sequelae, it is important to better understand the physiopathology of so-called long COVID.
Method: To this aim, we recruited 29 patients hospitalized for SARS-CoV-2 infection and, by Luminex, quantified 19 soluble factors in their plasma and in the supernatant of their peripheral blood mononuclear cells, including inflammatory and anti-inflammatory cytokines and chemokines, Th1/Th2/Th17 cytokines, and endothelium activation markers. We also measured their T4, T8 and NK differentiation, activation, exhaustion and senescence, T cell apoptosis, and monocyte subpopulations by flow cytometry.
Front Immunol
November 2022
Institute of Human Genetics, Unité Mixte de Recherche 9002 (UMR9002), Centre National de Recherche Scientifique (CNRS) and Montpellier University, Montpellier, France.
Cells
July 2020
Institute of Human Genetics, UMR9002, CNRS and Montpellier University, 34396 Montpellier, France.
Cell Rep
March 2017
Unité Mixte de Recherche 5535, Institut de Génétique Moléculaire de Montpellier, CNRS and Montpellier University, 34293 Montpellier, France. Electronic address:
The nuclear cap-binding complex (CBC) stimulates processing reactions of capped RNAs, including their splicing, 3'-end formation, degradation, and transport. CBC effects are particular for individual RNA families, but how such selectivity is achieved remains elusive. Here, we analyze three main CBC partners known to impact different RNA species.
View Article and Find Full Text PDF